Investors

Financials & Filings

Document Details

Form
144
Filing Date
Jun 5, 2026
Document Date
Jun 5, 2026
Form Description
Filed by "insiders" prior intended sale of restricted stock.
Filing Group
Other
Company
Xenon Pharmaceuticals Inc.
Issuer
Xenon Pharmaceuticals Inc.

Filing Formats

View HTML
Download PDF
Download DOC

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Request Information

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals

Sign Up